The cost of Trulance (palovarotene) for Medicare beneficiaries can vary significantly. It is important to note that Trulance is not currently approved for Medicare coverage in the United States.
What is Trulance approved for?
Trulance is approved for the treatment of fibrodysplasia ossificans progressiva (FOP) in adult and pediatric patients aged two years and older [1]. It is also approved for the treatment of jongens-type osteogenesis imperfecta (OI) in pediatric patients aged two to less than 18 years who are malnourished [1].
How is Trulance covered by Medicare?
As Trulance is not currently approved for Medicare coverage, patients who are eligible for Medicare and require Trulance may face out-of-pocket expenses. Coverage decisions are made on a case-by-case basis by Medicare Administrative Contractors (MACs) for drugs that are not on the Medicare Part B or Part D formularies. In many instances, newer or specialty drugs may not have a pre-determined coverage policy.
What if Trulance isn't covered by Medicare?
If Trulance is not covered by Medicare, patients may explore other avenues for assistance. These can include patient assistance programs offered by the drug manufacturer, if available, or exploring co-pay assistance programs through foundations or non-profit organizations. Information on potential financial assistance can often be found on the drug's official website or by speaking with a healthcare provider or pharmacist.
What is the list price of Trulance?
The list price for Trulance is not publicly available through standard drug pricing databases. Drug prices can fluctuate and are often subject to negotiation between manufacturers, pharmacies, and insurance providers.
Where can I find more information on drug patents and exclusivity?
Information regarding drug patents and exclusivity, which can influence the availability and cost of medications, can be found on DrugPatentWatch.com [2].
Sources:
1. https://www.trulance.com/
2. https://drugpatentwatch.com/